STOCK TITAN

Hawkins, Inc. Reports Second Quarter Fiscal 2022 Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Hawkins, Inc. (HWKN) reported record fiscal Q2 2022 results for the three months ending September 26, 2021. Sales rose 24% to $183.3 million, driven by growth across all segments. Gross profit achieved $37.3 million, an increase of 14%, contributing to operating income of $19.6 million, up 18%. Diluted EPS reached $0.67, reflecting an 18% increase year-over-year. Operating cash flow also surged to $25.3 million. Despite these gains, a LIFO charge of $3 million impacted gross profit due to rising raw material costs. The company completed the Southeast Water Systems acquisition in September 2021.

Positive
  • Record quarterly sales of $183.3 million, a 24% year-over-year increase.
  • Gross profit increased by 14% to $37.3 million.
  • Operating income up 18% to $19.6 million.
  • Diluted EPS rose 18% to $0.67.
  • Record operating cash flow of $25.3 million.
Negative
  • LIFO charge of $3 million negatively impacted gross profit.
  • Supply chain challenges persist across all business segments.

MINNEAPOLIS, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three and six months ended September 26, 2021, its second quarter of fiscal 2022. Highlights include:

  • Record quarterly sales of $183.3 million, a 24% year-over-year increase, with increases in all three segments.
  • Record second quarter gross profit of $37.3 million, a 14% increase over the prior year, contributing to record second quarter operating income of $19.6 million, a 18% year-over-year increase.
  • Record second quarter diluted earnings per share (EPS) of $0.67, which was $0.10, or 18%, higher than the same period last year.
  • Record quarterly operating cash flow of $25.3 million, compared to $18.6 million a year ago, allowing continued repayment of debt, with its leverage ratio under 1.0x at quarter end.
  • Record second quarter earnings before interest, taxes, depreciation and amortization (EBITDA), a non-GAAP measure, of $26.6 million, a 14% increase over the prior year.
  • Completed the acquisition of Southeast Water Systems in Alabama in September, as previously announced.
  • Year-to-date operating income, net income and diluted EPS each increased 28% over the prior year.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

"We are pleased with our continued strong operating results in fiscal 2022, with record quarterly sales of $183 million contributing to an 18% increase in operating income over the prior year. Significant revenue growth in both our Industrial and Water Treatment segments was driven by increased sales volumes of many of our products and increased selling prices due to rising raw material costs. As a result of rising raw material costs, in the quarter we recorded a LIFO charge of $3 million, and nearly $5 million in the first six months of fiscal 2022, negatively impacting our gross profit. Even with this significant negative impact of LIFO, we were still able to grow our gross profit by 20% in both our Water Treatment and Industrial segments."

Mr. Hawkins continued, "Demand for products in our Health and Nutrition group remained steady in the second quarter, due to continued consumer focus on health and immunity products. In addition, like many industries, we have experienced supply chain challenges in each of our business segments and expect those supply chain challenges to continue. However, thanks to the efforts of our outstanding employees, the relationships we have with our vendors and the investments we have made in storage and infrastructure, we have been able to overcome these challenges and continue to serve our customers."

Second Quarter Financial Highlights:

Sales were $183.3 million for the second quarter of fiscal 2022, an increase of 24%, from sales of $147.8 million for the same period a year ago. Industrial segment sales increased $22.0 million, or 36%, to $83.2 million for the current quarter, from $61.2 million for the same period a year ago. The increase in Industrial sales was driven by increased sales of both our bulk products as well as our manufactured, blended and repackaged products, in particular certain of our agricultural and food ingredient products. Water Treatment segment sales increased $12.6 million, or 25%, to $62.1 million for the current quarter, from $49.5 million for the same period a year ago. Water Treatment sales increased as a result of increased demand for many of our products, as well as $4.9 million in added sales from the acquisitions of ADC and C&L Aqua in fiscal 2021. Sales for our Health and Nutrition segment increased $0.9 million, or 2%, to $38.0 million for the current quarter, from $37.1 million for the same period a year ago. The increase in Health and Nutrition sales was driven by increased sales of our specialty distributed products largely as a result of continued increased demand for ingredients used in health and immunity products.

Gross profit increased $4.5 million, or 14%, to $37.3 million, or 20% of sales, for the current quarter, from $32.8 million, or 22% of sales, for the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $3.0 million, primarily due to rising raw material prices. In the same quarter a year ago, the LIFO reserve increased, and gross profit decreased, by $0.2 million. Gross profit for the Industrial segment increased $2.2 million, or 20%, to $12.6 million, or 15% of sales, for the current quarter, from $10.4 million, or 17% of sales, for the same period a year ago. Total Industrial segment gross profit increased as a result of the increase in sales, partially offset by the negative $2.5 million year-over-year impact of the increase in the LIFO reserve. Gross profit for the Water Treatment segment increased $3.0 million or 21% to $17.5 million, or 28% of sales, for the current quarter, from $14.5 million, or 29% of sales, for the same period a year ago. Gross profit in our Water Treatment segment increased as a result of increased sales, including the added sales in the acquired businesses of ADC and C&L Aqua. Gross profit for our Health and Nutrition segment decreased $0.6 million, or 8%, to $7.2 million, or 19% of sales, for the current quarter, from $7.8 million, or 21% of sales, for the same period a year ago. The gross profit decline in our Health and Nutrition segment was a result of product mix changes as well as inventory adjustments of $1.0 million due to increased reserves for excess product on hand, in accordance with our reserve policies.

Company-wide selling, general and administrative expenses increased $1.5 million to $17.7 million, or 10% of sales, for the current quarter, compared to $16.2 million, or 11% of sales, for the same period a year ago. Expenses increased in part due to the added costs from the acquired businesses of ADC and C&L Aqua, including $0.3 million of expense for amortization of intangibles, as well as increased variable pay expense.

Our effective income tax rate was 27% for the current quarter, compared to 26% in the same period a year ago. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is currently expected to be approximately 26-27%.

Earnings before interest, taxes, depreciation and amortization ("EBITDA"), a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of EBITDA is presented below. EBITDA for the three months ended September 26, 2021 was $26.6 million, an increase of $3.2 million, or 14%, from EBITDA of $23.4 million for the same period a year ago. The increase was primarily due to improved gross profit.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, and with 45 facilities in 23 states, the Company creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $597 million of revenue in fiscal 2021 and has approximately 750 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.

    
Adjusted EBITDAThree Months Ended Six months ended
(In thousands)September 26, 2021 September 27, 2020 September 26, 2021 September 27, 2020
Net Income (GAAP)$14,133  $12,190  $30,761  $23,978 
Interest expense, net329  339  678  719 
Income tax expense5,330  4,374  10,703  8,621 
Amortization of intangibles1,551  1,447  3,132  2,715 
Depreciation expense4,403  4,134  8,757  8,350 
Non-cash compensation expense862  686  1,661  1,386 
Non-recurring acquisition expenses9  265  11  265 
Adjusted EBITDA$26,617  $23,435  $55,703  $46,034 
                

HAWKINS, INC.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)

  Three Months Ended Six Months Ended
  September 26, 2021 September 27, 2020 September 26, 2021 September 27, 2020
Sales $183,277   $147,801   $364,518   $290,973  
Cost of sales (145,990)  (115,004)  (288,257)  (227,200) 
Gross profit 37,287   32,797   76,261   63,773  
Selling, general and administrative expenses (17,679)  (16,221)  (34,535)  (31,259) 
Operating income 19,608   16,576   41,726   32,514  
Interest expense, net (329)  (339)  (678)  (719) 
Other income 184   327   416   804  
Income before income taxes 19,463   16,564   41,464   32,599  
Income tax expense (5,330)  (4,374)  (10,703)  (8,621) 
Net income $14,133   $12,190   $30,761   $23,978  
         
Weighted average number of shares outstanding - basic 20,986,542   21,055,782   21,010,422   21,053,022  
Weighted average number of shares outstanding - diluted 21,140,087   21,245,762   21,168,809   21,268,562  
Basic earnings per share $0.67   $0.58   $1.46   $1.14  
Diluted earnings per share $0.67   $0.57   $1.45   $1.13  
Cash dividends declared per common share $0.13000   $0.11625   $0.25250   $0.23250  
                     

HAWKINS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)

  September 26,
2021
 March 28,
2021
ASSETS    
CURRENT ASSETS:    
Cash and cash equivalents $6,802  $2,998 
Trade accounts receivables, net 90,057  90,603 
Inventories 70,338  63,864 
Income taxes receivable   175 
Prepaid expenses and other current assets 2,478  5,367 
Total current assets 169,675  163,007 
PROPERTY, PLANT, AND EQUIPMENT: 307,021  300,404 
Less accumulated depreciation 163,910  155,792 
Net property, plant, and equipment 143,111  144,612 
OTHER ASSETS:    
Right-of-use assets 11,045  11,630 
Goodwill 72,417  70,720 
Intangible assets, net of accumulated amortization 73,666  76,368 
Other 7,890  6,213 
Total other assets 165,018  164,931 
Total assets $477,804  $472,550 
LIABILITIES AND SHAREHOLDERS’ EQUITY    
CURRENT LIABILITIES:    
Accounts payable — trade $43,004  $37,313 
Accrued payroll and employee benefits 12,417  18,048 
Income tax payable 877   
Current portion of long-term debt 9,907  9,907 
Short-term lease liability 1,625  1,587 
Container deposits 1,528  1,452 
Other current liabilities 2,191  2,155 
Total current liabilities 71,549  70,462 
LONG-TERM DEBT, LESS CURRENT PORTION 73,891  88,845 
LONG-TERM LEASE LIABILITY 9,553  10,231 
PENSION WITHDRAWAL LIABILITY 4,455  4,631 
DEFERRED INCOME TAXES 24,445  24,445 
DEFERRED COMPENSATION LIABILITY 8,289  7,322 
OTHER LONG-TERM LIABILITIES 1,309  1,368 
Total liabilities 193,491  207,304 
COMMITMENTS AND CONTINGENCIES    
SHAREHOLDERS’ EQUITY:    
Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,888,923 and 20,969,746 shares issued and outstanding as of September 26, 2021 and March 28, 2021, respectively 209  210 
Additional paid-in capital 44,801  51,138 
Retained earnings 239,303  213,898 
Total shareholders’ equity 284,313  265,246 
Total liabilities and shareholders’ equity $477,804  $472,550 
         

HAWKINS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)

  Six Months Ended
  September 26,
2021
 September 27,
2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $30,761   $23,978  
Reconciliation to cash flows:    
Depreciation and amortization 11,889   11,065  
Operating leases 948   963  
Gain on deferred compensation assets (416)  (804) 
Stock compensation expense 1,661   1,386  
Other 54   135  
Changes in operating accounts providing (using) cash:    
Trade receivables 596   (5,811) 
Inventories (6,458)  (8,004) 
Accounts payable 5,116   (1,421) 
Accrued liabilities (5,392)  (2,320) 
Lease liabilities (991)  (963) 
Income taxes 1,053   792  
Other 1,261   1,142  
Net cash provided by operating activities 40,082   20,138  
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property, plant, and equipment (6,904)  (8,120) 
Acquisitions (1,200)  (25,000) 
Other 181   105  
Net cash used in investing activities (7,923)  (33,015) 
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends declared and paid (5,356)  (4,959) 
New shares issued 889   773  
Shares surrendered for payroll taxes (1,467)  (54) 
Shares repurchased (7,421)    
Net (payments on) proceeds from revolving loan (15,000)  16,000  
Net cash (used in) provided by financing activities (28,355)  11,760  
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 3,804   (1,117) 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 2,998   4,277  
CASH AND CASH EQUIVALENTS, END OF PERIOD $6,802   $3,160  
     
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Cash paid for income taxes $9,650   $7,845  
Cash paid for interest $563   $610  
Noncash investing activities - capital expenditures in accounts payable $1,076   $191  
           

HAWKINS, INC.
REPORTABLE SEGMENTS (UNAUDITED)
(In thousands)

  Industrial Water
Treatment
 Health and Nutrition Total
Three months ended September 26, 2021:        
Sales $83,168  $62,111  $37,998  $183,277 
Gross profit 12,564  17,518  7,205  37,287 
Selling, general, and administrative expenses 6,456  7,405  3,818  17,679 
Operating income 6,108  10,113  3,387  19,608 
Three months ended September 27, 2020:        
Sales $61,171  $49,540  $37,090  $147,801 
Gross profit 10,436  14,522  7,839  32,797 
Selling, general, and administrative expenses 6,429  5,573  4,219  16,221 
Operating income 4,007  8,949  3,620  16,576 
Six months ended September 26, 2021:        
Sales $169,018  $118,349  $77,151  $364,518 
Gross profit 26,818  33,752  15,691  76,261 
Selling, general and administrative expenses 12,697  14,467  7,371  34,535 
Operating income 14,121  19,285  8,320  41,726 
Six months ended September 27, 2020:        
Sales $132,673  $89,254  $69,046  $290,973 
Gross profit 22,893  25,861  15,019  63,773 
Selling, general and administrative expenses 12,496  10,866  7,897  31,259 
Operating income 10,397  14,995  7,122  32,514 
             

Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, the impact and severity of the COVID-19 outbreak, changes in the labor markets, our available cash for investments, our business capital needs, changes in competition and price pressure, changes in demand and customer requirements or processes for our products, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, our ability to locate suitable real estate for new branch additions, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 28, 2021, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts:        
Jeffrey P. Oldenkamp
Executive Vice President and Chief Financial Officer
612/331-6910
ir@HawkinsInc.com


FAQ

What were Hawkins, Inc.'s earnings results for Q2 2022?

Hawkins, Inc. reported record earnings with a diluted EPS of $0.67, a 24% increase in sales to $183.3 million, and operating income of $19.6 million for Q2 2022.

How did Hawkins, Inc. perform compared to last year?

Compared to the same period last year, Hawkins, Inc. saw a 24% increase in sales and an 18% increase in operating income.

What challenges did Hawkins, Inc. face in Q2 2022?

Hawkins, Inc. faced supply chain challenges across all business segments, along with a LIFO charge of $3 million that negatively impacted gross profit.

What were the sales figures for Hawkins, Inc.'s segments?

In Q2 2022, Industrial segment sales rose 36% to $83.2 million, Water Treatment sales increased 25% to $62.1 million, and Health and Nutrition sales grew 2% to $38.0 million.

What was Hawkins, Inc.'s operating cash flow in Q2 2022?

Hawkins, Inc. generated record operating cash flow of $25.3 million in Q2 2022.

Hawkins Inc

NASDAQ:HWKN

HWKN Rankings

HWKN Latest News

HWKN Stock Data

2.62B
19.12M
8.7%
70.18%
1.95%
Specialty Chemicals
Wholesale-chemicals & Allied Products
Link
United States of America
ROSEVILLE